Comparison Between Standard Hematological Parameters and Blood Doping Biomarkers in Dried Blood Spots Within the Athlete Population of Swiss Sport Integrity

Overview

Journal Front Sports Act Living

Date 2024 Oct 4

PMID 39364095

Authors

Jessica Almeida Oliveira

Francesco Loria

Celine Schobinger

Tiia Kuuranne

Claudia Mumenthaler

Nicolas Leuenberger

Affiliations

Soon will be listed here.

Abstract

Introduction: The study demonstrated the feasibility of incorporating RNA biomarkers, specifically 5-aminolevulinic acid synthase (ALAS2) and carbonic anhydrase 1 (CA1), to improve the hematological module of the Athlete Biological Passport (ABP) in routine antidoping context.

Objective: The aim was to investigate the implementation of reticulocyte (RET) related biomarkers, specifically ALAS2 and CA1, using quantitative reverse transcription polymerase chain reaction (RT-qPCR) on dried blood spots (DBS) from elite athletes. Hemoglobin changes over time in DBS samples was measured as well. Combining hemoglobin and messenger RNA (mRNA) analyses allowed to monitor alterations of the established marker, "DBS OFF-score".

Methodology: Ten athletes were selected for sampling by the Swiss national antidoping organization, Swiss Sports Integrity (SSI). Samples were collected, transported and analyzed for ABP following the World Anti-Doping Agency (WADA) procedures and spotted onto Protein Saver DBS cards.

Results: Most athletes exhibited stable biomarker levels, except for one individual involved in ski mountaineering, who demonstrated a sustained increase in ALAS2 compared to the individual baseline. This elevation could be due to blood withdrawal or other factors, such as doping with substances outside the targeted test menu.

Conclusion: In this study, RNA-biomarkers were successfully analyzed in routine blood samples, and the project demonstrated promising results for the implementation of ALAS2 and CA1 in routine analysis to complement the ABP.

References

Salamin O, Gottardo E, Schobinger C, Reverter-Branchat G, Segura J, Saugy M . Detection of Stimulated Erythropoiesis by the RNA-Based 5'-Aminolevulinate Synthase 2 Biomarker in Dried Blood Spot Samples. Clin Chem. 2019; 65(12):1563-1571. DOI: 10.1373/clinchem.2019.306829. View

Morkeberg J, Sharpe K, Belhage B, Damsgaard R, Schmidt W, Prommer N . Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers. Scand J Med Sci Sports. 2009; 21(2):235-43. DOI: 10.1111/j.1600-0838.2009.01033.x. View

Krumm B, Saugy J, Botre F, Faiss R . Impact of low-volume blood withdrawal on hematological biomarkers for the athlete biological passport. Drug Test Anal. 2023; 16(2):168-173. DOI: 10.1002/dta.3528. View

Loria F, Stutz A, Rocca A, Grabherr S, Kuuranne T, Pruijm M . Monitoring of hemoglobin and erythropoiesis-related mRNA with dried blood spots in athletes and patients. Bioanalysis. 2022; 14(5):241-251. DOI: 10.4155/bio-2021-0252. View

Capiau S, Stove V, Lambert W, Stove C . Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer. Anal Chem. 2012; 85(1):404-10. DOI: 10.1021/ac303014b. View

Capiau S, Wilk L, Aalders M, Stove C . A Novel, Nondestructive, Dried Blood Spot-Based Hematocrit Prediction Method Using Noncontact Diffuse Reflectance Spectroscopy. Anal Chem. 2016; 88(12):6538-46. DOI: 10.1021/acs.analchem.6b01321. View

Salamin O, Mignot J, Kuuranne T, Saugy M, Leuenberger N . Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion. Drug Test Anal. 2017; 10(3):604-608. DOI: 10.1002/dta.2240. View

Ashenden M, Gough C, Garnham A, Gore C, Sharpe K . Current markers of the Athlete Blood Passport do not flag microdose EPO doping. Eur J Appl Physiol. 2011; 111(9):2307-14. DOI: 10.1007/s00421-011-1867-6. View

Saugy M, Lundby C, Robinson N . Monitoring of biological markers indicative of doping: the athlete biological passport. Br J Sports Med. 2014; 48(10):827-32. DOI: 10.1136/bjsports-2014-093512. View

10.

Solheim S, Ringsted T, Nordsborg N, Dehnes Y, Levernaes M, Morkeberg J . No pain, just gain: Painless, easy, and fast dried blood spot collection from fingertip and upper arm in doping control. Drug Test Anal. 2021; 13(10):1783-1790. DOI: 10.1002/dta.3135. View

11.

Andersen A, Nordsborg N, Bonne T, Bejder J . Contemporary blood doping-Performance, mechanism, and detection. Scand J Med Sci Sports. 2022; 34(1):e14243. DOI: 10.1111/sms.14243. View

12.

Sottas P, Robinson N, Saugy M . The athlete's biological passport and indirect markers of blood doping. Handb Exp Pharmacol. 2009; (195):305-26. DOI: 10.1007/978-3-540-79088-4_14. View

13.

Saugy M, Leuenberger N . Antidoping: From health tests to the athlete biological passport. Drug Test Anal. 2020; 12(5):621-628. DOI: 10.1002/dta.2773. View

14.

Ishii H, Shibuya M, Kusano K, Sone Y, Kamiya T, Wakuno A . Pharmacokinetic Study of Vadadustat and High-Resolution Mass Spectrometric Characterization of its Novel Metabolites in Equines for the Purpose of Doping Control. Curr Drug Metab. 2022; 23(10):850-865. DOI: 10.2174/1389200223666220825093945. View

15.

Pottgiesser T, Sottas P, Echteler T, Robinson N, Umhau M, Schumacher Y . Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study. Transfusion. 2011; 51(8):1707-15. DOI: 10.1111/j.1537-2995.2011.03076.x. View

16.

Schumacher Y, Saugy M, Pottgiesser T, Robinson N . Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport. Drug Test Anal. 2012; 4(11):846-53. DOI: 10.1002/dta.406. View

17.

Robinson N, Kirchbichler A, Banuls O, Mader M, Aikin R, Sottas P . Validation of a Blood Stability Score as an easy-to-use blood sample quality index. Int J Lab Hematol. 2016; 38(6):685-693. DOI: 10.1111/ijlh.12557. View

18.

Andersen A, Bejder J, Bonne T, Sorensen H, Sorensen H, Jung G . Hepcidin and Erythroferrone Complement the Athlete Biological Passport in the Detection of Autologous Blood Transfusion. Med Sci Sports Exerc. 2022; 54(9):1604-1616. DOI: 10.1249/MSS.0000000000002950. View

19.

Loria F, Cox H, Voss S, Rocca A, Miller G, Townsend N . The use of RNA-based 5'-aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses. Drug Test Anal. 2021; 14(5):826-832. PMC: 9545850. DOI: 10.1002/dta.3123. View

20.

Zhang L, Farrell J, Zhou H, Elashoff D, Akin D, Park N . Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2009; 138(3):949-57.e1-7. PMC: 2831159. DOI: 10.1053/j.gastro.2009.11.010. View